Development of enteric coated tablets from spray dried extract of feverfew (Tanacetum parthenium L.)

Brazilian Journal of Pharmaceutical Sciences

Volumn 45, Issue 3, 2009, Pages 573-584

  Chaves, Juliana Siqueira ^a   Da Costa, Fernando Batista ^a   De Freitas, Luís Alexandre Pedro ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Enteric coated tablets; Flavonoids; Parthenolide; Phytomedicine; Spray dried extract; Tanacetum parthenium

Indexed keywords

ANTIINFLAMMATORY AGENT; FLAVONOID; PARTHENOLIDE; SANTIN; TANACETUM PARTHENIUM EXTRACT; UNCLASSIFIED DRUG;

ARTICLE; DRUG COATING; DRUG FORMULATION; DRUG ISOLATION; DRUG SOLUBILITY; HARDNESS; MOISTURE; NONHUMAN; PARTICLE SIZE; PHYSICAL CHEMISTRY; SCANNING ELECTRON MICROSCOPE; TABLET COMPRESSION; TABLET DISINTEGRATION; TANACETUM PARTHENIUM; WETTABILITY;

EID: 76149130086     PISSN: 19848250     EISSN: 21759790     Source Type: Journal    
DOI: 10.1590/S1984-82502009000300024     Document Type: Article

References (41)

1. ABOURASHED, E.A.; KHAN, I.A. Determination of parthenolide in selected feverfew products by liquid chromatography. J. AOAC Int., Gaithersburg, v.4, p.789-792, 2000.
2. BARNES, J. Quality, efficacy and safety of complementary medicines: fashions, facts and the future. Part I. Regulation and quality. Br. J. Clin. Pharmacol., Oxford, v.55, p.226-233, 2003.
3. BOLHMANN, F.; ZDERO, C. Sesquiterpene lactones and other constituents from Tanacetum parthenium. Phytochemistry, Oxford, v.10, p.2543-2549, 1982.
4. CALIXTO, J.B. Efficacy, safety, quality control, marketing and regulatory guidelines for herbal medicines (phytotherapeutic agents). Braz. J. Med. Biol. Res., Ribeirão Preto, v.33, p.179-189, 2000.
5. CHAVES, J.S.; DA COSTA, F.B. A proposal for the quality control of Tanacetum parthenium (feverfew) and its hydroalcoholic extract. Rev. Bras. Farmacogn., João Pessoa, v.18, p.360-366, 2008.
6. DE PAULA, I.C. Desenvolvimento tecnológico de forma farmacêutica plástica contendo extrato seco nebulizado de Achyrocline satureoides (Lam.) DC. Compositae - marcela, Porto Alegre, 1996. 194p. [Dissertação de Mestrado: Faculdade de Ciências Farmacêuticas. UFRGS].
7. ENDALE, A.; SCHMIDT, P.C; GEBRE-MARIAM, T. Standardisation and physicochemical characterisation of the extracts of seeds of Glinus lotoides. Pharmazie, Eschborn, v.59, p.34-38, 2004.
8. FARMACOPÉIA BRASILEIRA. 4. ed. São Paulo: Editora Atheneu, 2000. 495 p.
9. FUKUDA, K.; HIBIYA, Y.; MUTOH, M.; OHNO, Y.; YAMASHITA, K.; AKAO, S.; FUJIWARA, H. Inhibition by parthenolide of phorbol ester-induced transcriptional activation of inducible nitric oxide synthase gene in a human monocyte cell line THP-1. Biochem. Pharmacol., Oxford, v.60, p.595-600, 2000.
10. GARCIA-PIÑERES, A.J.; CASTRO, V.; MORA, G.; SCHMIDT, T.J.; STRUNCK, E.; PAHL, H.L.; MERFORT, I. Cysteine 38 in p65/NF-kB plays a crucial role in DNA binding inhibition by sesquiterpene lactones. J. Biol. Chem., Maryland, v.276, p.39713-39720, 2001.
11. GARCIA-PIÑERES, A.J.; LINDENMEYER, M.T.; MERFORT, I. Role of cysteine residues of p65/ NFkB on the inhibition by the sesquiterpene lactone parthenolide and N-ethyl maleimide, and on its transactiving potential. Life Science, Amsterdam, v.75, p.841-856. 2004.
12. GRUENWALD, J.; BRENDLER, T.; JAENICKE, C. PDR for Herbal Medicines. 2 ed., Montvale, New Jersey: Medical Economics Company, 2000. p.306-309.
13. HWANG, D.; FISCHER, N.H.; JANG, B.C.; TAK, H.; KIM, J.K.; LEE, W. Inhibition of the expression of inducible cyclooxygenase and proinflammatory cytokines by sesquiterpene lactones in macrophages correlates with the inhibition of MAP kinases. Biochem. Biophys. Res. Commun., San Diego, v.226, p.810-818, 1996.
14. JOHNSON, E.S.; KADAM, N.P.; HYLANDS, D.M.; HYLANDS, P.J. Efficacy of feverfew as prophylactic treatment of migraine. Br. Med. J., London, v.291, p.6495-6569, 1985.
15. KAWASHIMA, Y.; TANKANORI, S.; HINO, T.; YAMAMOTO, H.; TAKEUCHI, H. Design of inhalation dry powder of pranlukast hydrate to improve dispersibility by the surface modification with light anhydrous silicic acid (Aerosil 200). Int. J. Pharm., Amsterdan, v.173, p.243-251, 1998.
16. KHAN, S.I.; ABOURASHED, E.A.; KHAN, I.A.; WALKER, L.A. Transport of parthenolide across human intestinal cells (Caco-2). Planta Med., Stutgartt, v.69, p.1009-1012, 2003.
17. KFURI, C.; FREITAS, L. A. P. A comparative study of spouted and spout fluid beds for Tablets coating. Dry. Technol., Philadelphia, v.23, p.2369-2388, 2006.
18. KWOK, B.H.B.; KOH, B.; NDUBUISI, M.I.; ELOFSSON, M.; CREWS, C.M. The anti-inflammatory natural product parthenolide from the medicinal herb feverfew directly binds to and inhibits IkB kinase. Chem. Biol., London, v.8, p.759-766, 2001.
19. LINDEN, R.; ORTEGA, G.G.; PETROVICK, P.R.; BASSANI, V.L. Response surface analysis applied to the preparation of tablets containing a high concentration of vegetable. Drug Develop. Ind. Pharm., Philadelphia, v.4, p.444-446, 2000.
20. LIST, P.H.; SCHMIDT, P.C. Medicinal Forms. In: Phytopharmaceutical Technology. Boston: Boca Raton, 1989. p.1-20
21. LONG, C.; SAULEAU, P.; DAVID, B.; LAVAUD, C.; CASSABOIS, V.; AUSSEIL, F.; MASSIOT, G. Bioactive flavonoids of Tanacetum parthenium revisited. Phytochemistry, Oxford, v.64, p.567-569, 2003.
22. MURPHY, J.J.; HEPTINSTALL, S.; MITCHELL, J.R.A. Randomized double-blind placebo-controlled trial of feverfew in migraine prevention. Lancet, London, v.2, p.189-192, 1988.
23. O'HARA, M.A.; KIEFER, D.; FARRELL, K.; KEMPER, K. A review of 12 commonly used medicinal herbs. Arch. Fam. Med., Chicago, v.7, p.523-536, 1998.
24. PALEVITCH, D.; EARON, G.; CARASSO, R. Feverfew (Tanacetum parthenium) as a prophylactic treatment for migraine: a double-blind placebo-controlled Study. PTR, Phytother. Res., West Sussex, v.11, p.508-511, 1997.
25. PALMA, S.; LUJÁN, C.; LLABOT, J.M.; BARBOZA, G.; MANZO, R.H.; ALLEMANDI, D.A. Design of Peumus boldus Tablets by direct compression using a novel dry plant extract. Int. J. Pharm., Amsterdam, v.233, p.191-198, 2002.
26. PEREIRA, C.A.M.; YARIWAKE, J.H.; LANÇAS, F.M.; WAUTERS, J.; TITS, M.; ANGENOT, L. A HPLC densitometric determination of flavonoids from Passiflora alata, P. edulis, P. incarnata and P. caerulea and comparison with HPLC method. Phytochem. Anal., West Sussex, v.15, p.241-248, 2004.
27. PFAFFENRATH, V.; DIENER, H.C.; FISCHER, M.; FRIEDE, M.; ZEPELIN, H.H.H. The efficacy and safety of Tanacetum parthenium (feverfew) in migraine prophylaxis - a double-blind, multicentre, randomized placebo-controlled dose-response study. Cephalalgia, Oxfordshire, v.22, p.523-532, 2002.
28. RUNHA, F.P.; CORDEIRO, D.S.; PEREIRA, C.A.M.; VILEGAS, J.; OLIVEIRA, W.P. Production of dry extracts of medicinal Brazilian plants by spouted bed process: Development of the process and evaluation of thermal degradation during the drying operation. Food Bioproducts Processing, Rugdby, v.79, p.1-9, 2001.
29. SILANO, M.; DE VICENZI, M.; DE VICENZI, A.; SILANO, V. The new European legislation on traditional herbal medicines: main features and perspectives. Fitoterapia, Amsterdam, v.75, p.107-116, 2004.
30. SHARIFF, A.; MANNA, P. K.; PARANJOTHY, K. L. K.; MANJULA, M. Entrapment of andrographolide in cross-linked alginate pellets: II. Physicochemical characterization to study the pelletization of andrographolide. Pakistan J. Pharm. Sci., Karachi, v.2, p.9-15, 2007.
31. SWAROSK, Y.L. Powder testing guide methods of measuring the physical properties of bulk powders. New York: Elsevier Applied Science, 1987. 146 p.
32. SENNA, E.L.; PETROVICK, G.; ORTEGA, G.G. BASSANI, V.L. Preparation and characterization of spray-dried powders from Achyrocline satureoides (Lam.) DC extracts. PTR, Phytother. Res., West Sussex, v.11, p.123-127, 1997.
33. STEFANELLO, M.E.A.; ALVARENGA, M.A. Constituents of Talauma ovata Bark. Fitoterapia, Amsterdam, v.68, p.465-476, 1997.
34. UNITED STATES PHARMACOPOEIA. 23 ed. Rockville: United States Pharmacopoeia Convention, 1995. 2391p.
35. VOGLER, B.K.; PITTLER, M.H.; ERNST E. Feverfew as a preventive treatment for migraine: a systematic review. Cephalalgia, Oxfordshire, v.18, p.705-708, 1998.
36. VON EGGELKRAUT-GOTTANKA, S.G.; ABED, S.A.; MÜLLER, W.; SCHMIDT PC. Roller compaction and tabletting of St. John's wort plant dry extract using a gap width and force controlled roller compactor. I. Granulation and tabletting of eight different extract batches. Pharm. Dev. Technol., London, v.7, p. 433-445, 2002.
37. 2A receptors. J. Nat. Prod., Washington, v.60, p.651-653, 1997.
38. WILLIAMS, C.A.; HARBONE, J.B.; GEIGER, H.; HOULT, J.R.S. The flavonoids of Tanacetum parthenium and T. vulgare and their anti-inflammatory properties. Phytochemistry, Oxford, v.51, p.417-423, 1999.
39. YUNES, R.A.; PEDROSA, R.C.; CECHINEL FILHO,V. Fármacos e fitoterápicos: a necessidade do desenvolvimento da indústria de fitoterápicos e fitofármacos no Brasil. Quím. Nova, Campinas, v. 24, p.147-152, 2001.
40. ZHANG, X. ; WANG, Y. ; WANG, J, WANG, Y.; LI, S. Effect of pore former on the properties of casted film prepared from blends of Eudragit NE 30 D and Eudragit L 30 D-55. Chem. Pharm. Bull., Tokyo, v.55, p.1261-1263, 2007.
41. ZHOU, J.Z.; KOU, X.; STEVENSON D. Rapid extractions and high-performance liquid chromatographic determination of parthenolide in feverfew (Tanacetum parthenium). J. Agric. Food Chem., Washington, v.47, p.1018-1022, 1999.